Financials
Financial year 2024
Apotheek Wijgmaal Brug from Leuven, company number BE0457651542, closed financial year 2024 with a result of € 118,834 after tax. For that financial year Apotheek Wijgmaal Brug recorded a gross margin of € 166,796 and equity of € 309,371. Compared with financial year 2023, the result moved from € 99,115 to € 118,834. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2025.
€ 309,371
▲ 23% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 118,834
▲ 20% vs 2023
Profit after tax over the fiscal year.
€ 45,241
▼ 28% vs 2023
Cash and bank balances on the last day of the fiscal year.
€ 60,000 paid out
50 % of the profit went to the shareholders, mostly to Leuven Pharma Services (100 % of the shares). That is where the money ends up.
People and assets in 2024
€ 41
▼ 96% vs 2023
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 4,192
▼ 31% vs 2023
Book value of vehicles, furniture and equipment.
Debts at end 2024
€ 87,220
▼ 12% vs 2023
€ 38,943 is repaid this year. At this pace the long-term loan is gone in ≈ 1 years.
€ 44,861
▼ 29% vs 2023
Supplier invoices still open on the last day of the fiscal year.
€ 1,611
▲ € 1,583 vs 2023
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2021 | 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|---|
| Gross margin | € 189,670 | € 167,081 | € 129,083 | € 166,796 | ▲ 29% |
| Profit after taxes | € 158,079 | € 143,180 | € 99,115 | € 118,834 | ▲ 20% |
| Equity | € 250,241 | € 250,421 | € 250,536 | € 309,371 | ▲ 23% |
| Total debts | € 452,828 | € 412,448 | € 387,578 | € 356,283 | ▼ 8% |
| Cash | € 7,931 | € 35,133 | € 62,605 | € 45,241 | ▼ 28% |
| Land & buildings | € 274,349 | € 256,928 | € 239,508 | € 222,087 | ▼ 7% |
| Retained profit | € 188,267 | € 188,448 | € 188,563 | € 247,397 | ▲ 31% |
| Dividend | € 156,900 | € 143,000 | € 99,000 | € 60,000 | ▼ 39% |
| Bank debt | € 169,580 | € 131,906 | € 98,813 | € 87,220 | ▼ 12% |
| Balance sheet total | € 703,069 | € 662,869 | € 638,114 | € 665,654 | ▲ 4% |
Key figures of Apotheek Wijgmaal Brug, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to Apotheek Wijgmaal Brug?
What happened at Apotheek Wijgmaal Brug in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: profit of € 118,834 (▲ 20% vs 2023). filed late Source: NBB ↗
- New establishment in Leuven. KBO
- Start of the company according to the CBE. KBO
In short
From € 158,079 profit in 2021 to € 118,834 profit in 2024.
Paid € 19,470 in corporate taxes since 2021.
Best year ever: 2021, with € 158,079 profit.
Paid out € 458,900 in dividends to the owners in total.
A new publication or filing at Apotheek Wijgmaal Brug? We notify you, reason included.
Follow Apotheek Wijgmaal BrugDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of Leuven Pharma Services comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
Apotheek Wijgmaal BrugBehind Apotheek Wijgmaal Brug are Katleen Quisthoudt and Leuven Pharma Services BV. The shares are held by Leuven Pharma Services (100%).
Directors
According to the 2024 annual accounts
Katleen Quisthoudt
Director
Also active at: Apotheek Wijgmaal Dorp, Leuven Pharma Services, De Vliegende Apotheker, PHARMA SERVICE BRABANT
Director · represented by Kristien Doms
Also active at: Apotheek Wijgmaal Dorp
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Vaartdijk 11 box 1
3018 Leuven
Casinolaan 38
3018 Leuven
Active since 18 February 1997
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 6 companies are registered at this address.
All companies at this address →Pardimmo
€ 43,746 gross margin · 2025
Apotheek Wijgmaal Dorp same network
€ 202,175 gross margin · 2024
Beheer Van Den Borre
€ -99 gross margin · 2025
Leuven Pharma Services same network
€ 190,635 gross margin · 2025
Wipoli
+1 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0457.651.542
- VAT number
- BE 0457.651.542
- Registered office
- Vaartdijk 11 bus 1, 3018 Leuven
- Names & denominations
- Apotheek Wijgmaal Brug
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 29 March 1996
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers